Autres langues Pacira BioSciences, Inc.

Actions

PCRX

US6951271005

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 22/05/2024			Varia. 5j.	Varia. 1 janv.
30,72 ^USD	-0,58 %		+2,13 %	-8,95 %

08/05	PACIRA BIOSCIENCES, INC. : Needham & Co. maintient sa recommandation à l'achat	ZM
07/05	Transcript : Pacira BioSciences, Inc., Q1 2024 Earnings Call, May 07, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

PACIRA BIOSCIENCES, INC. ANNOUNCES PRICING OF $250.0 MILLION AGGREGATE PRINCIPAL AMOUNT OF 2.125% CONVERTIBLE SENIOR NOTES DUE 2029	13/05
Pacira BioSciences Prices $250 Million Convertible Senior Notes Offering	10/05
Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029	10/05
Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029	10/05
Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior Notes	08/05
Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior Notes	08/05
Pacira BioSciences : 1Q 2024 Earnings Presentation	07/05
Pacira: Q1 Earnings Snapshot	07/05
Pacira BioSciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05
Earnings Flash (PCRX) PACIRA BIOSCIENCES Reports Q1 Revenue $167.1M, vs. Street Est of $165.7M	07/05
Pacira BioSciences, Inc. announces an Equity Buyback for $150 million worth of its shares.	07/05
Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase program	07/05
Pacira Biosciences, Inc. Reiterates Earnings Guidance for the Full Year 2024	07/05
Pacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference	07/05
Pacira BioSciences, Inc. authorizes a Buyback Plan.	07/05
Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024	30/04
Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference	02/04
Los bancos occidentales advierten de los riesgos del plan de la UE para usar los activos rusos	22/03
Beyond the Pill: Athletes Champion PEMF and Non-Opioid Solutions for Pain Management (ENDV)	20/03
Pacira BioSciences Says US FDA Granted Knee Osteoarthritis Therapy Candidate RMAT Designation	13/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Pacira BioSciences, Inc.

Actions

PCRX

US6951271005

Autres langues

Filtres